4 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 2 Not applicable, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Glycosuria: new trials by email Literature Review of Glycosuria trials Research Report on Glycosuria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of SGLT2 on Glucosuria in HNF1A-MODY Hyperglycaemic clamp, Placebo, Empagliflozin - Maturity-Onset Diabetes of the Young, Type 3, Type 2 Diabetes | Not applicable | Completed | Steno Diabetes Center Copenhagen | 21 | 2022-06-22 | 2023-07-27 |
| Human Solute Carrier Family 5 Member 2 (SLC5A2) Deficiency and the Glucagon-Incretin Axis Mixed-meal-tolerance-test - Familial Renal Glucosuria, Diabetes Mellitus | Unknown | Medical University Innsbruck | 10 | 2019-01-24 | 2019-05-29 | |
| Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I) Type II Diabetes Mellitus | Unknown | Zhongda Hospital | 20000 | 2017-01-01 | 2017-05-08 | |
| Genetics of Response to Canagliflozin Canagliflozin - Diabetes Mellitus, Type 2 | Phase 1 | Active not recruiting | University of Maryland, Baltimore | 700 | 2016-09-01 | 2025-12-18 |
| A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus ASP1941, acarbose, Placebo - Type II Diabetes Mellitus | Phase 3 | Terminated | Astellas Pharma Inc | 46 | 2012-04-23 | 2024-11-12 |
| A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients ASP1941, metformin, Placebo - Type II Diabetes Mellitus | Phase 3 | Completed | Astellas Pharma Inc | 171 | 2011-11-28 | 2024-11-12 |
| Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action Dapagliflozin, Placebo - Insulin Sensitivity, Multiple Mitochondrial Dysfunctions Syndrome | Not applicable | Completed | The University of Texas Health Science Center at San Antonio | 18 | 2011-03-01 | 2025-07-03 |
| A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese Subjects ASP1941, Placebo - Healthy, Pharmacokinetics of ASP1941 | Phase 1 | Completed | Astellas Pharma Inc | 56 | 2011-02-01 | 2011-10-12 |
| National Registry of Rare Kidney Diseases Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis | Recruiting | UK Kidney Association | 35000 | 2009-11-06 | 2023-10-04 |
Diabetes Mellitus, Type 2 (5) · Glycosuria, Renal (2) · Adenine phosphoribosyltransferase deficiency (1) · Atypical Hemolytic Uremic Syndrome (1) · Bartter Syndrome (1) · Calciphylaxis (1) · Cardiovascular Diseases (1) · Cystinosis (1) · Cystinuria (1) · Dent Disease (1) · Denys-Drash Syndrome (1) · Diabetes Insipidus, Nephrogenic (1) · Diabetes Mellitus (1) · Fabry Disease (1)
Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Glucose Metabolism Disorders (9) · Male Urogenital Diseases (9) · Metabolic Diseases (9) · Nutritional and Metabolic Diseases (9) · Urination Disorders (9) · Urogenital Diseases (9) · Urologic Diseases (9) · Endocrine System Diseases (7) · Diabetes Mellitus (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Kidney Diseases (2)
ipragliflozin (3) · Acarbose (1) · Canagliflozin (1) · Metformin (1) · dapagliflozin (1) · empagliflozin (1)
Astellas Pharma Inc (3) · Medical University Innsbruck (1) · Steno Diabetes Center Copenhagen (1) · The University of Texas Health Science Center at San Antonio (1) · UK Kidney Association (1) · University of Maryland, Baltimore (1) · Zhongda Hospital (1)
Taiwan (3) · South Korea (2) · Austria (1) · China (1) · Denmark (1) · United Kingdom (1) · United States (1)
Devjit Tripathy, MD (1) · Ralph DeFronzo, MD (1) · Simeon I Taylor, MD, PhD (1)
PMID 27561923, PMID 31606880, PMID 37608471, PMID 37738422, PMID 37738423, PMID 38481375, PMID 38947416
R01DK024092 (1), R01DK118942 (1)